Express Scripts Holding Company (ESRX) : Washington Trust Bank scooped up 292 additional shares in Express Scripts Holding Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 4, 2016. The investment management firm now holds a total of 38,200 shares of Express Scripts Holding Company which is valued at $2,686,988.Express Scripts Holding Company makes up approximately 0.64% of Washington Trust Bank’s portfolio.
Other Hedge Funds, Including , Eqis Capital Management reduced its stake in ESRX by selling 2,676 shares or 16.56% in the most recent quarter. The Hedge Fund company now holds 13,486 shares of ESRX which is valued at $948,605. Express Scripts Holding Company makes up approx 0.06% of Eqis Capital Management’s portfolio.Beacon Financial Group reduced its stake in ESRX by selling 736 shares or 1.18% in the most recent quarter. The Hedge Fund company now holds 61,452 shares of ESRX which is valued at $4,322,534. Express Scripts Holding Company makes up approx 0.91% of Beacon Financial Group’s portfolio.
Express Scripts Holding Company closed down -0.05 points or -0.07% at $69.91 with 21,33,836 shares getting traded on Tuesday. Post opening the session at $69.85, the shares hit an intraday low of $69.69 and an intraday high of $70.52 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Express Scripts Holding Company reported $1.57 EPS for the quarter, based on the information available during the earnings call on Jul 25, 2016. Analyst had a consensus estimate of $1.57. The company had revenue of $25222.00 million for the quarter, compared to analysts expectations of $25392.31 million. The company’s revenue was down -.9 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.44 EPS.
Many Wall Street Analysts have commented on Express Scripts Holding Company. Company shares were Reiterated by Mizuho on Aug 2, 2016 to “Neutral”, Firm has raised the Price Target to $ 82 from a previous price target of $77 .